VOLUME
67 2006 NUMBER 5
Original Articles
688 Prospective, Long-Term, Multicenter Study of the Naturalistic
Outcomes of Patients With Treatment-Resistant Depression. David L. Dunner,
A. John Rush, James M. Russell, Michael Burke, Stacy Woodard, Peggy Wingard,
and John Allen
[Abstract]
[PDF]
696 An Open-Label Study of the Tolerability of Mixed Amphetamine Salts in
Adults With Attention-Deficit/Hyperactivity Disorder and Treated Primary
Essential Hypertension. Timothy E. Wilens, Randall M. Zusman, Paul G.
Hammerness, Amy Podolski, Julia Whitley, Thomas J. Spencer, Martin Gignac,
and Joseph Biederman
[Abstract]
[PDF]
703 The Brown Longitudinal Obsessive Compulsive Study: Clinical Features
and Symptoms of the Sample at Intake. Anthony Pinto, Maria C. Mancebo,
Jane L. Eisen, Maria E. Pagano, and Steve A. Rasmussen
[Abstract]
[PDF]
712 Agitated "Unipolar" Major Depression: Prevalence, Phenomenology, and
Outcome. [CME]
Mario Maj, Raffaele
Pirozzi, Lorenza Magliano, Andrea Fiorillo, and Luca Bartoli
[Abstract]
[PDF]
720 The Prescription of Psychotropic Medications for Patients Discharged
From a Psychiatric Emergency Service. Carrie L. Ernst, Suzanne A. Bird,
Joseph F. Goldberg, and S. Nassir Ghaemi
[Abstract]
[PDF]
727 A Comparison of Once-Daily and Divided Doses of Modafinil in Children
With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind,
Placebo-Controlled Study. Joseph Biederman, James M. Swanson, Sharon B.
Wigal, Samuel W. Boellner, Craig Q. Earl, and Frank A. Lopez, for the
Modafinil ADHD Study Group
[Abstract]
[PDF]
736 Bupropion Extended Release Compared With Escitalopram: Effects on
Sexual Functioning and Antidepressant Efficacy in 2 Randomized,
Double-Blind, Placebo-Controlled Studies. Anita H. Clayton, Harry A.
Croft, Joseph P. Horrigan, Donna S. Wightman, Alok Krishen, Nathalie E.
Richard, and Jack G. Modell
[Abstract]
[PDF]
747 Prediction of Recurrence in Recurrent Depression and the Influence of
Consecutive Episodes on Vulnerability for Depression: A 2-Year Prospective
Study. Claudi L. H. Bockting, Philip Spinhoven, Maarten W. J. Koeter,
Luuk F. Wouters, and Aart H. Schene, for the Depression Evaluation
Longitudinal Therapy Assessment (DELTA) Study Group
[Abstract]
[PDF]
756 Lithium and Clozapine Rechallenge: A Retrospective Case Analysis.
Richard A. Kanaan and Robert W. Kerwin
[Abstract]
[PDF]
761 Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female
Patients: Data From 7 Randomized, Double-Blind, Placebo-Controlled Trials.
Susan G. Kornstein, Madelaine M. Wohlreich, Craig H. Mallinckrodt, John
G. Watkin, and Donna E. Stewart
[Abstract]
[PDF]
771 Efficacy and Safety of Pregabalin in the Treatment of Generalized
Anxiety Disorder: A 6-Week, Multicenter, Randomized, Double-Blind,
Placebo-Controlled Comparison of Pregabalin and Venlafaxine. Stuart A.
Montgomery, Kathy Tobias, Gwen L. Zornberg, Siegfried Kasper, and Atul C.
Pande
[Abstract]
[PDF]
783 Prevalence and Clinical Correlates of Medical Comorbidities in
Patients With Bipolar I Disorder: Analysis of Acute-Phase Data From a
Randomized Controlled Trial. Wesley K. Thompson, David J. Kupfer, Andrea
Fagiolini, John A. Scott, and Ellen Frank
[Abstract]
[PDF]
789 Glucose Metabolism in Patients With Schizophrenia Treated With
Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance
Test and Minimal Model Analysis. David C. Henderson, Paul M. Copeland,
Christina P. Borba, Tara B. Daley, Dana D. Nguyen, Enrico Cagliero, A. Eden
Evins, Hui Zhang, Doug L. Hayden, Oliver Freudenreich, Corinne Cather, David
A. Schoenfeld, and Donald C. Goff
[Abstract]
[PDF]
798 A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine
Combination and Olanzapine Monotherapy in the Treatment of Bipolar
Depression. Sara A. Corya, Roy H. Perlis, Paul E. Keck, Jr., Daniel Y.
Lin, Michael G. Case, Doug J. Williamson, and Mauricio F. Tohen
[Abstract]
[PDF]
Focus on Childhood and Adolescent Mental Health
807 Improving the Recognition and Treatment of Childhood and Adolescent
Mental Illness. Melissa P. DelBello
[PDF]
808 Juvenile Maladaptive Aggression: A Review of Prevention, Treatment,
and Service Configuration and a Proposed Research Agenda. [CME]
Daniel F. Connor, Gabrielle A. Carlson, Kiki D. Chang,
Peter T. Daniolos, Reuven Ferziger, Robert L. Findling, Janice G.
Hutchinson, Richard P. Malone, Jeffrey M. Halperin, Belinda Plattner, Robert
M. Post, Diane L. Reynolds, Kenneth M. Rogers, Kirti Saxena, and Hans
Steiner, for the Stanford/Howard/AACAP Workgroup on Juvenile Impulsivity and
Aggression
[Abstract]
[PDF]
821 Psychiatric Comorbidity Assessed in Korean Children and Adolescents
Who Screen Positive for Internet Addiction. Jee Hyun Ha, Hee Jeong Yoo,
In Hee Cho, Bumsu Chin, Dongkeun Shin, and Ji Hyeon Kim
[Abstract]
[PDF]
827 Validation of the Mood Disorder Questionnaire for Bipolar Disorders
in Adolescents. Karen Dineen Wagner, Robert M. A. Hirschfeld, Graham J.
Emslie, Robert L. Findling, Barbara L. Gracious, and Michael L. Reed
[Abstract]
[PDF]
ASCP Corner
831 Commentary on the Clinical Antipsychotic Trials of Intervention
Effectiveness (CATIE). John M. Kane
[PDF]
A Psychiatrist's Diary
833 No Further History. Shyam K. Bhat
[PDF]
Letters To the Editor
835 A Case of Pulmonary Thromboembolism and Rhabdomyolysis During Therapy
With Mirtazapine and Risperidone. Mathias Zink, Udo Knopf, Sotiria Argiriou, and Anna Kuwilsky
[PDF]
835 Repetitive Transcranial Magnetic Stimulation for Maintenance
Treatment of Depression: A Case Report. Berthold Langguth, Michael Landgrebe, Marc Zowe, Maria Gerst, Göran
Hajak, and Peter Eichhammer
[PDF]
836 Open Study of Creatine Monohydrate in Treatment-Resistant
Posttraumatic Stress Disorder. Daniela Amital, Tali Vishne, Suzana Roitman, Moshe Kotler, and Joseph
Levine
[PDF]
837 Long-Term Outcome of Vagus Nerve Stimulation in Rapid-Cycling Bipolar
Disorder. Malek Bajbouj, Heidi Danker-Hopfe, Isabella Heuser, and Ion Anghelescu
[PDF]
838 QTc and Metabolic Parameters. W. Victor R. Vieweg
[PDF]
- Reply by Paul Mackin and Allan H. Young
Book Reviews 840